ELDN

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Irvine, California, dedicated to developing pioneering therapies for patients with autoimmune diseases and amyotrophic lateral sclerosis (ALS), particularly those in need of organ or cell transplantation. The company is advancing its proprietary drug candidates through a series of rigorous clinical trials, targeting significant unmet medical needs. With a robust pipeline and a strategic focus on enhancing transplant outcomes, Eledon is poised to play a transformative role in the biopharmaceutical landscape, aiming to significantly improve the quality of life for patients confronting these complex health challenges.